BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28636713)

  • 1. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.
    Auffenberg GB; Lane BR; Linsell S; Cher ML; Miller DC
    JAMA Surg; 2017 Oct; 152(10):978-980. PubMed ID: 28636713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Taneja SS
    J Urol; 2015 Jan; 193(1):128-9. PubMed ID: 25523659
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 7. Urologists reduce overtreatment in prostate cancer.
    Das M
    Lancet Oncol; 2018 Aug; 19(8):e384. PubMed ID: 29937393
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
    Gaylis F; Nasseri R; Salmasi A; Anderson C; Mohedin S; Prime R; Swift S; Dato P; Cohen E; Catalona W; Topp R; Friedman L; Kane C
    Urology; 2021 Jul; 153():139-146. PubMed ID: 33482125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in prostate cancer care.
    Ghani KR; Miller DC
    JAMA; 2015 May; 313(20):2066-7. PubMed ID: 26010635
    [No Abstract]   [Full Text] [Related]  

  • 10. Physician social networks and variation in prostate cancer treatment in three cities.
    Pollack CE; Weissman G; Bekelman J; Liao K; Armstrong K
    Health Serv Res; 2012 Feb; 47(1 Pt 2):380-403. PubMed ID: 22092259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Gaylis F; Cohen E; Calabrese R; Prime H; Dato P; Kane CJ
    Urology; 2016 Jul; 93():60-7. PubMed ID: 26876460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative.
    Burks FN; Hu JC; Telang D; Liu A; Hawken S; Montgomery Z; Linsell S; Montie JE; Miller DC; Ghani KR;
    J Urol; 2017 Aug; 198(2):322-328. PubMed ID: 28257783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in management of low-risk prostate cancer: how registries may change the world.
    Cooperberg MR
    Eur Urol; 2015 Jan; 67(1):51-52. PubMed ID: 25242556
    [No Abstract]   [Full Text] [Related]  

  • 14. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
    Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N
    Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer.
    Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML
    J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic variation in the treatment of prostate cancer in Connecticut.
    Polednak AP
    Int J Technol Assess Health Care; 1993; 9(2):304-10. PubMed ID: 8458708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The practice of Scottish urologists in the assessment and management of fracture risk in the ageing male being treated for prostate cancer.
    Ngu WS; Byrne DJ
    ScientificWorldJournal; 2007 Sep; 7():1590-5. PubMed ID: 17906821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
    Xu J; Bock C; Janisse J; Schwartz KL; Triest J; Cher ML; Goodman M
    Urology; 2021 Sep; 155():83-90. PubMed ID: 33482128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of the Choosing Wisely Campaign in Urology.
    Welk B; Winick-Ng J; McClure JA; Lorenzo AJ; Kulkarni G; Ordon M
    Urology; 2018 Jun; 116():81-86. PubMed ID: 29572056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.